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with corneal-compensated intraocular pressure in
the evaluation of primary open-angle Glaucoma
Joshua R Ehrlich1, Nathan M Radcliffe1* and Mitsugu Shimmyo2Abstract
Background: To better understand the role of corneal properties and intraocular pressure (IOP) in the evaluation of
primary open-angle glaucoma (POAG); and to determine the feasibility of identifying glaucomatous optic
neuropathy (GON) using IOP corrected and uncorrected for corneal biomechanics.
Methods: Records from 1,875 eyes of consecutively evaluated new patients were reviewed. Eyes were excluded if
central corneal thickness (CCT) or Ocular Response Analyzer (ORA) measurements were unavailable. Presence or
absence of GON was determined based on morphology of the optic disc, rim and retinal nerve fiber layer at the
time of clinical examination, fundus photography and Heidelberg Retinal Tomography. Goldmann-applanation
tonometry (GAT) in the untreated state was recorded and Goldmann-correlated (IOPg) and corneal-compensated
IOP (IOPcc) were obtained using the ORA. Glaucomatous eyes were classified as normal or high-tension (NTG, HTG)
using the conventional cutoff of 21 mm Hg. One eligible eye was randomly selected from each patient for
inclusion.
Results: A total of 357 normal, 155 HTG and 102 NTG eyes were included. Among NTG eyes, IOPcc was greater
than GAT (19.8 and 14.4 mm Hg; p < 0.001) and the difference between IOPcc and GAT was greatest for this
subgroup of patients with NTG (p≤ 0.01). The maximum combined sensitivity and specificity for detection of GON
occurred at 20.9 mm Hg for GAT (59%, 90%) and 18.4 mm Hg for IOPcc (85%, 85%) and the area under the curve
was greater for IOPcc (0.93 vs. 0.78; p < 0.001).
Conclusions: IOPcc may account for measurement error induced by corneal biomechanics. Compared to GAT,
IOPcc may be a superior test in the evaluation of glaucoma but is unlikely to represent an effective diagnostic test.
Keywords: Open-angle glaucoma, Low tension glaucoma, Intraocular pressure, Intraocular pressure, Ocular
tonometryBackground
Glaucoma is an optic neuropathy for which intraocular
pressure (IOP) is the only known modifiable risk factor.
Historically, elevated IOP was essential to the diagnosis
of glaucoma, however the current American Academy of
Ophthalmology definition does not include elevated IOP
as a requirement [1,2]. IOP as measured by Goldmann
applanation tonometry (GAT) does not correlate well
with glaucomatous optic neuropathy (GON) as there are* Correspondence: nmr9003@med.cornell.edu
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reproduction in any medium, provided the orentities such as ocular hypertensive eyes with elevated
GAT readings without GON as well as normal tension
glaucoma (NTG) eyes with progressive GON despite
normal or low GAT measurements [3-6].
Notwithstanding, data from clinical trials support a
role for IOP reduction in patients with ocular hyperten-
sion, early or advanced primary open-angle glaucoma
(POAG), and NTG [7-11]. As IOP remains the only
modifiable risk factor for eyes with GON and IOP re-
duction remains the mainstay of treatment, greater ac-
curacy and less confounding in IOP measurement
should have value in the management of most glauco-
mas [7-11]. It is not entirely clear whether theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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related to shortcomings of office based IOP measure-
ment, or whether IOP-independent risk factors are re-
sponsible for the pathological process in some
glaucomas. While both may be operative, there is evi-
dence that in applanation tonometry various factors can
cause systematic measurement errors. In fact, Goldmann
warned that extremely thick corneas would be measured
inaccurately [12]. Ehlers measured IOP by in vivo can-
nulation of human eyes and introduced a table to cor-
rect the GAT errors caused by variations in central
corneal thickness (CCT) measured by optical pachyme-
try [13]. Liu and Roberts quantitatively analyzed the the-
oretically larger effect of biomechanical properties of the
cornea in addition to corneal curvature and thickness
[14]. Also, recent studies have shown that GAT calibra-
tion error is common [15].
The Ocular Response Analyzer (ORA; Reichert Oph-
thalmic Instruments, Buffalo, NY) functions as a non-
contact tonometer and was designed to provide IOP
assessments that are independent of CCT. The instru-
ment provides a Goldmann-correlated measure of IOP
(IOPg) and a corneal compensated IOP (IOPcc) that is
not correlated with CCT [16]. A number of investigators
have illustrated that the ORA may avoid some of the
aforementioned drawbacks of GAT, including confound-
ing by corneal thickness, calibration error, and concerns
regarding contamination and sanitation [17-21]. It has
been demonstrated that IOPg serves as a good approxi-
mation of GAT and may offer the clinician a tool to
transition toward a corneal compensated IOP without
fully abandoning GAT [17,22]. Ultimately, transitioning
to a corneal compensated measure of IOP might provide
the clinician with a better approximation of anterior
chamber pressure, independent of corneal biomechanical
properties [18,21,23,24].
It is unclear whether an IOP estimation less affected
by confounding corneal properties could more effect-
ively detect and/or aid in the evaluation and manage-
ment of glaucoma. In the present study we sought to
compare the sensitivity and specificity of measurements
corrected and uncorrected for corneal biomechanics
for the detection of GON in a population of patients
under evaluation in a comprehensive ophthalmology
office.
Methods
Data collection for this cross-sectional retrospective
study was performed within the private office of one of
the authors (MS). Approval for this cross-sectional
retrospective study was obtained from the institutional
review board at the New York Eye and Ear Infirmary
and this investigation adhered to the tenets of the Dec-
laration of Helsinki.We reviewed IOP measurements for 1,875 consecutive
eyes of new patients evaluated from January 2, 2004 to
December 31, 2007 in a comprehensive ophthalmology
practice in New York City. Consecutive patients with or
without glaucoma undergoing initial eye examination
were included in the study. Eyes were classified as nor-
mal or glaucomatous based on the absence or presence
of morphological GON ascertained by clinical examin-
ation, fundus photography and Heidelberg Retinal Tom-
ography II (Heidelberg Engineering, Heidelberg,
Germany) of the optic disc and neuroretinal rim using
previously defined criteria [25] that include changes such
as: optic disc asymmetry, vertical/horizontal disparity,
rim area and rim volume asymmetry, notching of the
rim, violation of the ISNT rule and disc hemorrhages,
with or without visual field defects, regardless of IOP
level.
Eyes of patients without clinically evident GON were
designated as a normal group, including patients under
evaluation for glaucoma who were generally referred on
the basis on family history or physiologic cupping.
All included patients had undergone CCT measure-
ments with the DGH 550 pachette ultrasonic pachy-
meter (DGH Technologies, Pensylvania) and evaluation
with the ORA (Reichert Inc, Depew, NY). Eyes without
documented CCT or ORA measurements were
excluded. All patients in this practice underwent routine
CCT and ORA assessment regardless of diagnosis or
reason for referral; however these were not always per-
formed on the same visit and patients were only
included when these data were acquired on the same
date. Other exclusion criteria included acute or chronic
angle closure glaucoma; secondary glaucoma; pseudoex-
foliation syndrome; eyes with previous medical, laser or
surgical treatment for glaucoma or corneal conditions;
and lens and vitreous opacities that prevented optic
nerve and retinal nerve fiber examinations. In addition,
eyes were excluded if there was a history or diagnosis of
ischemic optic neuropathy, vascular occlusive diseases,
cerebrovascular accident, or other pertinent neurological
disease. Data were extracted for analysis by randomly
selecting one eye of each subject.
The highest GAT value recorded in an eye in the un-
treated state (no ocular hypotensive medication) was
included for analysis. Topical anesthetic and fluorescein
was placed in each eye before GAT, which was per-
formed immediately after ORA evaluation per office
protocol. The GAT used for the study was checked
monthly to ensure proper calibration. Additionally, IOPg
and IOPcc values were collected from the ORA. Per
office protocol, ORA measurements were repeated five
times or until a waveform score of 6.5 was obtained, and
the measurement with the best waveform score was
selected for inclusion in the study.
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21 mm Hg, we divided the population of all glaucomat-
ous eyes into 2 groups: eyes with GAT greater than
21 mm Hg were designated as high-tension glaucoma
(HTG); and eyes with GAT of 21 mm Hg or less as
NTG. NTG eyes were then subdivided by IOPcc values;
IOPcc greater than 21 mm Hg (high IOPcc NTG) and
IOPcc less than or equal to 21 mm Hg (low IOPcc
NTG). In each category and subgroup, age, GAT, IOPg
and IOPcc were compared.
Differences in age, GAT, IOPg and IOPcc were
determined among normal, HTG and NTG eyes. Sen-
sitivity and specificity of GAT and IOPcc for the detec-
tion of GON at different thresholds of IOP were
determined from the entire study population of normal
and glaucomatous eyes; presence or absence of GON,
as previously described, was designated as the gold
standard for comparison. Receiver operating character-
istic (ROC) curves of GAT and IOPcc were then con-
structed. The optimum IOP cutoff was defined as the
value corresponding to the point on the ROC curve
closest to the upper-left corner. A multiple ANOVA
and post-hoc analyses were also performed and Benfer-
roni corrections were applied when indicated. All stat-
istical tests were two-sided with a 0.05 level of
significance.
Results
A total of 1,261 normal eyes were excluded due to
absence of CCT or ORA measurements. Demographic
and IOP data for normal, HTG and NTG eyes areTable 1 Patient characteristics
Category Normal
Criteria No GON
Number of patients/eyes 357
Age (years), mean± SD 62.3 ± 13.4
GAT (mm Hg) 14.0 ± 2.4
IOPg (mm Hg) 14.0 ± 3.0
IOPcc (mm Hg) 14.5 ± 3.1
IOPcc-GAT (mm Hg) 0.5 ± 1.7







*p≤ 0.05 for comparison with normal group.
^p≤ 0.05 for comparison between NTG and HTG groups.
HTG: high-tension glaucoma; NTG: normal-tension glaucoma; GON: glaucomatous o
Goldman-correlated intraocular pressure; IOPcc: corneal compensated intraocular pshown in Table 1 for the 614 patients included in
the study (357 normal, 155 POAG HTG, 102 POAG
NTG).
Frequency distributions of IOP measurements in nor-
mal and glaucomatous eyes are shown in Figure 1. GAT
was chosen to represent IOP in normal eyes since all
pressure measurements (GAT, IOPg and IOPcc) were
statistically equivalent in this group (p > 0.05). The fre-
quency distribution of both GAT and IOPcc is illustrated
for all glaucomatous eyes (Figure 1).
Among NTG eyes, mean IOPcc was significantly
higher than mean GAT (19.8 vs. 14.4 mm Hg; p < 0.001).
Furthermore, the difference between GAT and IOPcc
(expressed as [IOPcc – GAT] ) was significantly greater
in NTG (5.4 ± 1.1 mm Hg) than in either normal
(0.5 ± 1.7 mm Hg; p < 0.001) or HTG eyes (1.2 ± 1.2 mm
Hg; p < 0.001). CCT was significantly correlated with
IOPcc in NTG (p = 0.01) but not normal (p = 0.48) or
HTG eyes (p = 0.93).
In this study, NTG eyes were defined as eyes with
GON and a maximum recorded GAT less than or equal
to 21 mm Hg. However, 39 (38%) of the 102 GAT
defined NTG eyes had an IOPcc higher than 21 mm Hg;
the mean IOPcc of these eyes was 23.3 mm Hg (Table 2).
Of the same cohort of NTG eyes, 73 (72%) had an IOPcc
greater than 18 mm Hg, 93 (91%) had an IOPcc greater
than 15 mm Hg, and only 9 eyes (9%) had an IOPcc of
15 mm Hg or less.
Sensitivities and specificities for identifying glaucoma
using GAT (Figure 2a) and IOPcc (Figure 2b) were
determined from the total study population of normalHTG NTG
GON+GAT> 21 mm Hg GON+GAT≤ 21 mm Hg
155 102
66.3 ± 12.7* 68.7 ± 10.9*
25.3 ± 5.6*^ 14.4 ± 3.4^
26.5 ± 5.5*^ 14.4 ± 3.4^
25.3 ± 5.5*^ 19.8 ± 3.4*^
1.2 ± 1.2*^ 5.4 ± 1.1*^







ptic neuropathy; GAT: Goldmann applanation tonometry; IOPg:
ressure; CCT: central corneal thickness.
Figure 2 Sensitivity and specificity of GAT and IOPcc in
detecting glaucomatous optic neuropathy. a. Sensitivity and
specificity of GAT in detecting glaucoma. b. Sensitivity and
specificity of IOPcc in detecting glaucoma.
Figure 1 Frequency distributions of IOP measurements in
normal and glaucomatous eyes. Frequency distribution of GAT in
normal (solid line); GAT in glaucoma (dashed line); and IOPcc in
glaucoma (fine dotted line); p < 0.001 for each pair-wise comparison.
GAT, IOPg and IOPcc of normal eyes were statistically similar
(p > 0.05), and are therefore represented by GAT (solid line).
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gold standard reference. The traditional GAT threshold
of 21 mm Hg had a sensitivity of 46% (specificity 99%)
for detecting glaucoma. The optimal GAT threshold to
maximize combined sensitivity and specificity was
20.9 mm Hg (sensitivity 59%, specificity 90%). Likewise,
an IOPcc cutoff of 18.4 mm Hg resulted in the highest
combination of sensitivity (85%) and specificity (85%) for
detecting glaucoma. The areas under the curve (AUC) of
ROC curves were compared and demonstrated a greater
AUC for IOPcc (0.93) compared to GAT (0.78) in the
detection of GON (test for difference of AUCs:
p < 0.001) Figure 3.Table 2 Normal-tension glaucoma patient characteristics
Category All NTG
Criteria GAT≤ 21 mm Hg GAT≤
Number of patients/eyes 102
Age (years), mean± SD 68.7 ± 10.9
GAT (mm Hg) 14.4 ± 3.4
IOPg (mm Hg) 14.4 ± 3.4
IOPcc (mm Hg) 19.8 ± 3.4
IOPcc-GAT (mm Hg) 5.4 ± 1.1







*p≤ 0.05 for comparison between NTG with high IOPcc and NTG with low IOPcc.
HTG: high-tension glaucoma; NTG: normal-tension glaucoma; GON: glaucomatous o
Goldman-correlated intraocular pressure; IOPcc: corneal compensated intraocular pDiscussion
In this comparison of several different assessments of
IOP for the detection of GON, we found evidence that
an IOP assessment that compensates for cornealNTG with high IOPcc NTG with low IOPcc
21 mm Hg, IOPcc > 21 mm Hg GAT≤ 21 mm Hg, IOPcc≤ 21
39 63
70.0 ± 8.6* 67.8 ± 12.1*
17.6 ± 1.4* 12.4 ± 2.6*
17.6 ± 1.4* 12.4 ± 2.6*
23.3 ± 1.4* 17.7 ± 2.4*
5.6 ± 1.0 5.2 ± 1.1







ptic neuropathy; GAT: Goldmann applanation tonometry; IOPg:
ressure; CCT: central corneal thickness.
Figure 3 ROC curves for GAT and IOPcc. ROC curves of GAT and
IOPcc in the detection of GON (orange line-GAT; black line-IOPcc).
The AUC for GAT was 0.78 and for IOPcc was 0.93 (test for difference
of AUCs: p < 0.001).
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the detection of POAG than GAT. Specifically, we found
that GAT and IOPcc showed considerable agreement
within the normal and HTG cohorts. However, among
NTG eyes IOPcc was, on average, significantly higher
than GAT. Moreover, we determined that the optimal
threshold for GAT to maximize sensitivity and specificity
for the detection of GON was 20.9 mm Hg and for
IOPcc was 18.4 mm Hg. Using ROC curves we found
that the AUC for the IOPcc (0.93) was greater than for
GAT (0.78), indicating that compared to GAT, IOPcc
may represent a superior test in the evaluation of
glaucoma.
Importantly, we would like to emphasize that we do
not support the use of even a corneal compensated IOP
for the diagnosis of glaucoma. Due to the relatively low
prevalence of POAG in the population [26-29], a diag-
nostic test with a sensitivity and specificity of 85% would
result in low positive predictive value and thus a high
number of false-positives. For example, in a population
with a 4% prevalence of undiagnosed POAG, only about
19% of patients with a positive result would have the dis-
ease. Additionally, with a sensitivity of 85%, approxi-
mately one in six patients with POAG would not be
detected. Notwithstanding, IOPcc may represent a better
tool for the evaluation and management of POAG due
to its more consistent association with the disease across
a wide range of IOPs.
Since IOPcc was greater than GAT in majority of
NTG eyes (92%) in this study, segregating NTG andHTG using a GAT threshold of 21 mm Hg may not be
optimal. Other studies have also demonstrated an under-
estimation of IOP by applanation tonometry after cor-
recting IOP for corneal properties [18,21,30-33]. The
present study, like others, found that eyes with NTG
had significantly thinner corneas [34,35], while patients
with HTG had greater CCT compared to normals. Of
note, one study, the Low Tension Glaucoma Study, did
not find abnormally low CCT in a cohort of NTG
patients [36]. However, the current study suggests that
the impact of corneal properties on IOP determination
may be greatest in eyes with NTG.
Past investigations have demonstrated that IOPcc is
less dependent on corneal properties than traditional
contact tonometry [18,23]. Medeiros and Weinreb found
that CCT was significantly correlated with GAT but not
IOPcc in a population under evaluation for glaucoma.
Additionally, in the same study they found that the dif-
ference between GAT and IOPcc increased linearly as a
function of increasing CCT [18]. The results of the
present investigation are similar in that we observed no
significant correlation between CCT and IOPcc among
HTG and normal eyes. However, we did determine a sig-
nificant correlation between CCT and IOPcc among eyes
with NTG. This pattern may exist since lower IOP
values have a greater biologically plausible range for up-
ward adjustment due to CCT than do higher IOP values
as a function of regression toward the mean. This find-
ing suggests that an accurate algorithm to correct for
the impact of CCT and/or corneal biomechanics on IOP
is likely to be non-linear.
CCT is lowest in eyes with NTG [34,35] and low CCT
may be both an independent risk factor for glaucoma
progression [8] as well as a source of IOP measurement
error [30-33]. Consequently, use of a corneal compen-
sated IOP may be preferable to GAT specifically in the
evaluation and management of NTG. The existence of
higher than normal IOPcc in eyes with NTG is sup-
ported by reports that medical and surgical therapies
that decrease IOP in NTG eyes are effective in reducing
the progression of GON [10,11]. In the Collaborative
Normal Tension Glaucoma Treatment Study [10], the
average baseline IOP in the treated and untreated arms
was 16.1 and 16.9 mm Hg, respectively. With treatment,
the average IOP in the treatment group was lowered to
10.6 mm Hg, while IOP in the control group remained
16.0 mm Hg. Importantly, 35% of untreated eyes and
only 12% of treated eyes met criteria for visual field or
glaucomatous optic disc progression at the end of the
study [10].
Notwithstanding, it has been observed that some eyes
with NTG progress despite ocular hypotensive therapy
[10]. In fact, some have speculated that NTG eyes may
even develop GON independent of IOP [37]. Given the
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IOPcc and GAT in a single patient may be as large as
8 mm Hg, an eye with a GAT value in the normal range
may actually have a much higher IOPcc, depending on
its corneal properties. In this context, setting a thera-
peutic target IOP using GAT would similarly differ from
an IOPcc target pressure. This may partially explain
glaucoma progression in NTG eyes in which IOP, as
measured by GAT, appears to be adequately controlled
since determining a safe IOP target is made difficult.
There are several limitations to this study. As an ob-
servational cross-sectional study, it is not possible to
determine how the longitudinal risk of glaucoma pro-
gression is related to GAT compared to IOPcc. The op-
erational definition of GON used in this study was
based on the appearance of the optic nerve as docu-
mented by the evaluating clinician and data for other
definitions of glaucoma including visual field defects
are not available. While perimetric evaluation or other
computerized optic nerve imaging techniques could
have been employed, these devices have limitations
related to accuracy for GON detection [38] and such
testing was not performed on all patients in this study.
Additionally, since CCT [30] and CH [39,40] differ by
race/ethnicity it is possible that studies with distinct
ethnic compositions may yield different results. None-
theless, we did not separately analyze racial/ethnic dif-
ferences in CCT and their contribution to our results.
Finally, it was outside of the scope of this study to cor-
relate the degree of GON with IOP levels or their fluc-
tuation. Though we recognize that the absence of
diurnal IOP data may have resulted in misclassification
of some patients, there is no reason to believe that the
data were systematically biased toward IOP measure-
ment at any specific time of day.
This study contributes to the understanding of dif-
ferences that exist in the impact of corneal properties
on IOP measurement between normal, HTG and
NTG eyes. Importantly, these results suggest that the
a corneal compensated IOP may offer an attractive al-
ternative to GAT, particularly for the evaluation and
management of patients with NTG in whom corneal
biomechanics and thickness appear to play the greatest
role.
Conclusions
The sensitivity and specificity of GAT and corneal-
compensated IOPcc for the identification of GON were
optimized at thresholds of 20.9 and 18.4 mm Hg, re-
spectively. For the detection of GON, the area under the
ROC curve was significantly greater for IOPcc compared
to GAT. While IOP is unlikely to be an effective diag-
nostic test, the results of this study suggest that a
corneal-compensated IOP may represent a superior testfor the evaluation of glaucoma, especially among
patients with low to normal IOPs.
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